AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC is a Public Limited Company registered in United Kingdom under 11185179, and its current status with Companies House is active. The company was incorporated on 2 February 2018 and lists its registered address as London, United Kingdom. 2 shareholders are on record for AUTOLUS THERAPEUTICS PLC, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of AUTOLUS THERAPEUTICS PLC
Two shareholders are currently on record for AUTOLUS THERAPEUTICS PLC, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is Frazier Life Sciences Management, L.P. , holding 3.7% — the largest recorded stake — followed by Tema ETF Trust-Tema Oncology ETF at 0.1%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 3.7% | Companies House | |
| Tema ETF Trust-Tema Oncology ETF | 0.1% | Companies House |
Officers
5
Directors and officers of AUTOLUS THERAPEUTICS PLC
Three of the 5 officer records shown for AUTOLUS THERAPEUTICS PLC are current appointments, filed with Companies House. Cynthia Butitta (appointed 2018-06-15) and Ravi Rao (appointed 2024-04-01) both serve as Director; Alex Driggs (appointed 2021-10-06) serves as Company Secretary. The remaining 2 records shown (Matthias Alder and John Johnson) are former appointments that have since been resigned. Management authority at AUTOLUS THERAPEUTICS PLC sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 18 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Group Structure
Group structure of AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- AUTOLUS HOLDINGS (UK) LIMITED (United Kingdom)
- Autolus Inc. (United States)
Data availability
Those 2 subsidiaries span United Kingdom, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
AUTOLUS THERAPEUTICS PLC
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns AUTOLUS THERAPEUTICS PLC?
Two shareholders are currently on record for AUTOLUS THERAPEUTICS PLC, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is Frazier Life Sciences Management, L.P. , holding 3.7% — the largest recorded stake — followed by Tema ETF Trust-Tema Oncology ETF at 0.1%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is AUTOLUS THERAPEUTICS PLC's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for AUTOLUS THERAPEUTICS PLC is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does AUTOLUS THERAPEUTICS PLC have on record?
2 shareholders are shown on record for AUTOLUS THERAPEUTICS PLC.
What is AUTOLUS THERAPEUTICS PLC's company registration number?
AUTOLUS THERAPEUTICS PLC's registration number is 11185179, filed with Companies House in United Kingdom. Its current status on the register is active.
Is AUTOLUS THERAPEUTICS PLC still an active company?
AUTOLUS THERAPEUTICS PLC's status on Companies House is listed as active.
When was AUTOLUS THERAPEUTICS PLC incorporated?
AUTOLUS THERAPEUTICS PLC was incorporated on 2 February 2018, according to Companies House.
What is AUTOLUS THERAPEUTICS PLC's registered address?
The registered address on file for AUTOLUS THERAPEUTICS PLC is London, United Kingdom.
What legal structure is AUTOLUS THERAPEUTICS PLC registered as?
AUTOLUS THERAPEUTICS PLC is registered as a Public Limited Company in United Kingdom.
Who are the officers/directors of AUTOLUS THERAPEUTICS PLC?
Three of the 5 officer records shown for AUTOLUS THERAPEUTICS PLC are current appointments, filed with Companies House. Cynthia Butitta (appointed 2018-06-15) and Ravi Rao (appointed 2024-04-01) both serve as Director; Alex Driggs (appointed 2021-10-06) serves as Company Secretary. The remaining 2 records shown (Matthias Alder and John Johnson) are former appointments that have since been resigned. Management authority at AUTOLUS THERAPEUTICS PLC sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does AUTOLUS THERAPEUTICS PLC have a parent company or subsidiaries?
AUTOLUS THERAPEUTICS PLC has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span United Kingdom, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to AUTOLUS THERAPEUTICS PLC's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to AUTOLUS THERAPEUTICS PLC's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access AUTOLUS THERAPEUTICS PLC's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like AUTOLUS THERAPEUTICS PLC's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 22 September 2026.